Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 622,973
  • Shares Outstanding, K 34,706
  • Annual Sales, $ 45,470 K
  • Annual Income, $ 9,490 K
  • 60-Month Beta 0.92
  • Price/Sales 13.81
  • Price/Cash Flow 57.68
  • Price/Book 23.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.06
  • Number of Estimates 4
  • High Estimate 0.10
  • Low Estimate 0.04
  • Prior Year 0.06
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.56 +9.00%
on 08/06/20
29.01 -37.78%
on 07/13/20
-10.53 (-36.84%)
since 07/10/20
3-Month
16.56 +9.00%
on 08/06/20
29.73 -39.28%
on 07/10/20
-1.67 (-8.47%)
since 05/12/20
52-Week
7.51 +140.35%
on 12/20/19
29.73 -39.28%
on 07/10/20
+9.73 (+116.95%)
since 08/12/19

Most Recent Stories

More News
Zynex Announces Second Quarter 2020 Earnings

, /PRNewswire/ -- . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac...

ZYXI : 18.05 (+0.56%)
Zynex (ZYXI) to Report Q2 Earnings: What's in the Cards?

Zynex's (ZYXI) April orders down approximately 35% from the January and February average. This may have impacted its Q2 earnings.

IART : 50.82 (-0.68%)
LH : 188.10 (+1.06%)
ZYXI : 18.05 (+0.56%)
EXAS : 87.15 (+4.15%)
Zynex Schedules 2020 Second Quarter Earnings

ENGLEWOOD, Colo., /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management,...

ZYXI : 18.05 (+0.56%)
Zynex, Inc. Prices Public Offering of Common Stock

, /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation,...

ZYXI : 18.05 (+0.56%)
Zynex Inc. Announces Proposed Public Offering of Common Stock

, /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation,...

ZYXI : 18.05 (+0.56%)
Dow Sheds Nearly 7% as Pullback Finally Arrives

Dow Sheds Nearly 7% as Pullback Finally Arrives

ZYXI : 18.05 (+0.56%)
TTD : 460.03 (+3.23%)
KMX : 106.24 (+2.16%)
KEY : 12.89 (-1.45%)
UNP : 191.83 (+0.78%)
R : 40.01 (+2.91%)
RCL : 57.19 (-2.52%)
TPC : 12.84 (-1.68%)
GSKY : 4.89 (+0.20%)
VECO : 14.04 (+3.08%)
DNLI : 29.95 (-8.97%)
NASDAQ Finishes Above 10K with Third Straight Record Close

NASDAQ Finishes Above 10K with Third Straight Record Close

CMC : 22.78 (+1.29%)
NAV : 33.55 (-0.74%)
ZYXI : 18.05 (+0.56%)
TSLA : 1,554.76 (+13.12%)
MSFT : 209.19 (+2.86%)
AAPL : 451.91 (+3.29%)
AMZN : 3,162.24 (+2.65%)
Zynex Set to Join S&P SmallCap 600

, /PRNewswire/ -- Zynex Inc. (NASD:ZYXI) will replace KEMET Corp. (NYSE:KEM) in the S&P SmallCap 600 effective prior to the opening of trading on . Yageo Corp. is acquiring KEMET in a deal expected to...

ZYXI : 18.05 (+0.56%)
KEM : 27.21 (+0.07%)
SPGI : 349.19 (+1.59%)
Agios Gets Orphan Drug Tag for Mitapivat to Treat Thalassemia

The FDA confers an orphan drug status on Agios' (AGIO) pyruvate kinase-R activator mitapivat for addressing patients with thalassemia. Stock rises in after-hours trading.

ZYXI : 18.05 (+0.56%)
AGIO : 40.30 (-0.25%)
DSRLF : 202.1800 (+2.89%)
APYX : 5.22 (+0.58%)
Zynex Announces New Line of Products

, /PRNewswire/ -- . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac...

ZYXI : 18.05 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade ZYXI with:

Business Summary

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and...

See More

Key Turning Points

2nd Resistance Point 18.70
1st Resistance Point 18.38
Last Price 18.05
1st Support Level 17.72
2nd Support Level 17.38

See More

52-Week High 29.73
Fibonacci 61.8% 21.24
Fibonacci 50% 18.62
Last Price 18.05
Fibonacci 38.2% 16.00
52-Week Low 7.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar